BDBM192455 US10800746, Example WO 2011/104322 68::US9187466, 68::US9687476, 68

SMILES NC(=O)Cn1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nc1-c1ccccc1Cl

InChI Key InChIKey=CYQJEYVBTAZXQH-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 192455   

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 12nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 8.30nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 8.30nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 6nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 8.30nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent